XML 49 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 12 Stock-Based Compensation
6 Months Ended
Mar. 31, 2012
Share-based Compensation [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Stock-Based Compensation
 
Stock compensation expense was as follows:

 
Three Months Ended
 
Six Months Ended
 
March 31,
2012
 
April 2,
2011
 
March 31,
2012
 
April 2,
2011
 
(In thousands)
 
 
 
 
Cost of sales
$
983

 
$
1,013

 
$
1,890

 
$
2,052

Selling, general and administrative
3,519

 
3,184

 
6,649

 
5,790

Research and development
27

 
40

 
54

 
82

Total
$
4,529

 
$
4,237

 
$
8,593

 
$
7,924



 
Three Months Ended
 
Six Months Ended
 
March 31,
2012
 
April 2,
2011
 
March 31,
2012
 
April 2,
2011
 
(In thousands)
 
 
 
 
Stock options
$
2,547

 
$
2,661

 
$
5,002

 
$
5,411

Restricted stock units
1,982

 
1,576

 
3,591

 
2,513

Total
$
4,529

 
$
4,237

 
$
8,593

 
$
7,924



In March 2012, the Company's shareholders approved the reservation of an additional 2.5 million shares of common stock for future issuance under the Company's 2009 stock plan. As of March 31, 2012, an aggregate of 17.1 million shares were authorized under the plan and 3.6 million shares of common stock were available for grant under the Company's stock plans, which include stock options and restricted stock awards and units.

Stock Options

Assumptions used to estimate the fair value of stock options granted were as follows:

 
Three Months Ended
 
Six Months Ended
 
March 31,
2012
 
April 2,
2011
 
March 31,
2012
 
April 2,
2011
Volatility
85.8
%
 
82.6
%
 
85.6
%
 
82.3
%
Risk-free interest rate
0.9
%
 
2.1
%
 
0.9
%
 
1.7
%
Dividend yield
%
 
%
 
%
 
%
Expected life of options (years)
5.0

 
5.0

 
5.0

 
5.0


Stock option activity was as follows:
 
Number of
Shares
 
Weighted-
Average
Exercise Price
($)
 
Weighted-
Average
Remaining
Contractual
Term
(Years)
 
Aggregate
Intrinsic
Value of
In-The-Money
Options
($)
 
(In thousands)
 
 
 
 
 
(In thousands)
Outstanding, October 1, 2011
10,922

 
13.85

 
6.89

 
14,195

Granted
892

 
8.64

 
 
 
 
Exercised/Cancelled/Forfeited/Expired
(208
)
 
12.88

 
 
 
 
Outstanding, December 31, 2011
11,606

 
13.46

 
6.91

 
16,839

Granted
116

 
10.99

 
 
 
 
Exercised/Cancelled/Forfeited/Expired
(480
)
 
8.76

 
 
 
 
Outstanding, March 31, 2012
11,242

 
13.64

 
6.64

 
31,022

Vested and expected to vest, March 31, 2012
10,446

 
13.99

 
6.50

 
28,453

Exercisable, March 31, 2012
7,524

 
15.91

 
5.72

 
19,021



The weighted-average grant date fair value of stock options granted during the three and six months ended March 31, 2012 was $7.36 per share and $5.96 per share, respectively. The weighted-average grant date fair value of stock options granted during the three and six months ended April 2, 2011 was $10.52 per share and $9.00 per share, respectively. The aggregate intrinsic value in the preceding table represents the total pre-tax intrinsic value of in-the-money options that would have been received by the option holders had all option holders exercised their options at the Company's closing stock price on the date indicated.

As of March 31, 2012, unrecognized compensation expense related to stock options was $21.4 million, and is expected to be recognized over a weighted average period of 3.5 years.

Restricted Stock Units

The Company grants restricted stock units to executive officers, directors and certain management employees. These units vest over periods ranging from one to four years and are automatically exchanged for shares of common stock at the vesting date. Compensation expense associated with these units is recognized ratably over the vesting period.

As of March 31, 2012, unrecognized compensation expense related to restricted stock units was $14.1 million, and is expected to be recognized over a weighted average period of 1.8 years.

Activity with respect to the Company's restricted stock units was as follows:

 
Number of
Shares
 
Weighted-
Average Grant Date
Fair Value
($)
 
Weighted-
Average
Remaining
Contractual
Term
(Years)
 
Aggregate
Intrinsic
Value
($)
 
(In thousands)
 
 
 
 
 
(In thousands)
Outstanding, October 1, 2011
1,838

 
11.42

 
1.63

 
14,249

Granted
610

 
8.69

 
 
 
 
Vested/Cancelled
(235
)
 
11.39

 
 
 
 
Outstanding, December 31, 2011
2,213

 
10.67

 
1.79

 
19,119

Granted
175

 
11.44

 
 
 
 
Vested/Cancelled
(86
)
 
13.84

 
 
 
 
Outstanding, March 31, 2012
2,302

 
10.61

 
1.55

 
26,519

Expected to vest, March 31, 2012
1,717

 
10.36

 
1.55

 
19,776